Boston, Massachusetts 02115


The purpose of the research study is to identify the genetic, environmental and immune profiles that may increase a person's risk of developing multiple sclerosis (MS). While MS is not a disease caused by a single variation in genetic material (DNA), a single environmental factor, or a single malfunction in immune cells, there are genetic alterations, environmental exposures and immunologic factors that make the development of MS more likely. Obtaining information about who is at risk for MS will be beneficial in the future if the investigators can identify effective ways to prevent or slow down the progression of this disease.

Study summary:

MS is an autoimmune disease in which the immune system (white bloods cells that normally fight infection) becomes misdirected and attacks healthy tissue. In patients with MS, the misdirected white blood cells attack myelin, a lining that insulates the nerves found in your brain and spinal cord. This results in inflammation and damage in the myelin. Loss of this protective lining disrupts nerve impulses and causes abnormal function in the nervous system. This large research study will ultimately enroll over 5000 subjects who are at risk of developing MS.


Inclusion Criteria: - First Degree Relatives of Patients with MS, or - Patients who have received anti-TNFa therapy as treatment for inflammatory diseases other than MS such as Crohn's disease, psoriasis and rheumatoid arthritis, or - Patients that have been referred for an evaluation of first presentation of neurologic symptoms but do not have a diagnosis of MS - Live in the United States Exclusion Criteria: - Does not match any of the inclusion criteria



Primary Contact:

Study Director
Xongqi Xia, MD, PhD
Brigham and Womens Hospital

GEMS Coordinator, BS
Phone: 617-264-5980

Backup Contact:


Location Contact:

Boston, Massachusetts 02115
United States

Emily K Owen, BS
Phone: 617-264-5980

Site Status: Recruiting

Data Source:

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.